Services
Weight Loss
The injectable drug, initially only used as diabetes medication, is the
first drug since Saxenda (2014) approved to treat chronic weight
management in the 70% of American adults who are obese or overweight.
Research continues to show the effectiveness of semaglutide injections
for weight loss.
Tirzepatid acts on 2 receptors GLP-1 and GIP to decrease hunger, decrease
sugar cravings, delays gastric emptying, and regulate blood sugar.
Weight Loss
AKA “skinny shots” hits the value of treating obesity as a chronic metabolic disease instead of expecting people to rely solely on willpower and lifestyle changes to manage their condition.
Benefits
